In conclusion, sivelestat sodium acts as an effective clinical drug for the treatment of ARDS in animal models by inhibiting the release of apoptotic and inflammatory factors via the PI3K/AKT/mTOR signaling pathway. This evidence concerns the gene AKT1 and acute respiratory distress syndrome.